BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 281 filers reported holding BLUEBIRD BIO INC in Q2 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,816,000 | -11.6% | 107,797 | 0.0% | 0.52% | -27.3% |
| Q2 2020 | $6,580,000 | +113.7% | 107,797 | +60.9% | 0.71% | +65.0% |
| Q1 2020 | $3,079,000 | -38.4% | 67,000 | +17.5% | 0.43% | -21.4% |
| Q4 2019 | $5,002,000 | +4.8% | 57,000 | +9.6% | 0.55% | -8.5% |
| Q3 2019 | $4,775,000 | -46.4% | 52,000 | -25.7% | 0.60% | -38.9% |
| Q2 2019 | $8,904,000 | +2.9% | 70,000 | +27.3% | 0.98% | -3.1% |
| Q1 2019 | $8,653,000 | -26.0% | 55,000 | -53.3% | 1.01% | -24.3% |
| Q4 2018 | $11,691,000 | – | 117,850 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |